Med-Tech Innovation February 5, 2024
An independent assessment by analytics provider IQVIA in partnership with NHS England has found that Cyted’s diagnostic technology reduced the demand for endoscopies in secondary care by 78%, improved the patient experience and decreased costs for the UK health system.
Cyted CEO and co-founder Marcel Gehrung, said: “The findings of this report illustrate the significant national impact of embedding our capsule sponge technology. It has allowed patients waiting for endoscopy to be effectively prioritised, enabling those in urgent need of diagnosis to be tested more quickly, reducing waiting lists and decreasing pressure on health systems. We look forward to expanding the adoption of this technology, helping detect disease earlier and improve patient outcomes.”
Cyted’s capsule sponge technology, EndoSign is a...
Today's Sponsors
Today's Sponsor